Cervical cancer was the fourth most common cancer among women worldwide in 2022, according to the WHO. Against this backdrop, ...
Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.
The exceedingly low uptake of high-risk human papillomavirus (HPV) vaccine constitutes a critical gap in Pakistan’s public health strategy. Cervical cancer, primarily caused by HPV infections, is on ...
In this cross-sectional study of area deprivation, vaccination access, and human papillomavirus (HPV) vaccination status in Osaka ...
The Department of Health Research has informed a panel of lawmakers that trials are ongoing at three Indian Council of ...
The results, published in Current Oncology in December, showed 88 per cent of participants chose the self-sample option and ...
13h
MyChesCo on MSNAprea Therapeutics Teams Up with MD Anderson for Preclinical HNSCC ResearchAprea Therapeutics, Inc. (Nasdaq: APRE) has entered into a Material Transfer Agreement (MTA) with MD Anderson Cancer Center ...
Sarah was in hospital having a scan to find out why she was suddenly suffering from such heavy periods and severe pelvic pain ...
An HPV vaccine can prove to be crucial in preventing the cancer of the cervix, a leading cancer among women, a Parliamentary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results